CPHi (Convention on Pharmaceutical Ingredients) is
organizing a conference on pharmaceutical and bio-pharma intellectual property industry
from 31 January to 2 February 2012. As India is fast emerging as one of the
strongest markets in the global pharma industry, this conference brings
critical issues to the forefront and will help the attendees find answers to
the intellectual property concerns.
The conference is spread across three days, where first day
focuses on Indian perspective and the other two days provide international
perspectives. The speakers are top management professionals from leading global
and Indian pharmaceutical and biosciences companies.
The conference
provides excellent networking opportunity and insights into following topics:
Patentability
|
Section 3(d)
|
Compulsory licensing
|
Pre- grant and Post- grant Opposition
|
Data Exclusivity
|
Hatch Waxman Act
|
Paragraph IV filings
|
US Patent System
|
America Invents Act
|
Bio-similar Patents
|
Polymorph Patents
|
Freedom To Operate
|
Doctrine of Equivalents (DOE)
|
EU Patent Reforms
|
Supplementary
protection Certificate (SPCs)
|
In India, USA, EU, Japan, Brazil and China
|
Please
visit www.pharmaipr-india.com for registration and further
information. A special discount of 10% is available on the fee till 31 December
2011. Please don't forget to mention that you came through SiNApSE blog.
For further information, please contact Ms
Asan Bano on +91 (022) 4046 1466 or write to
conferences-india@ubm.com.
0 comments:
Post a Comment